Skip to main content

Table 3 Model typical values (tv) for isoflupredone following a single intra-articular administration of 8 mg of isoflupredone acetate (Predef® 2X) in the right antebrachiocarpal joint 12 h post intra-articular LPS administration, to exercised Thoroughbred horses (n = 8)

From: Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis

Parameter

Estimate

CV%

tvVplasma (mL)

423,442.6

19.7

tvCl (ng*h/mL)

337,682.9

11.2

tvVsyn (mL)

557.5

24.3

tvKap (1/h)

0.077

10.7

tvCLsyn (ng*h/mL)

22.5

33.2

dKapdLPS1

0.333

38.5

stdev0

0.249

4.67

stdev1

0.584

22.0

HLplasma (h)

0.869

18.1

Kap_HL (h)

9.03

10.7

Syn_HL (h)

17.1

19.8

Kap_LPS(1/h)

0.107

11.6

Kap_LPS_HL(h)

6.47

11.6

  1. tvVplasma denotes the value of the plasma volume of isoflupredone; tvCl the clearance of drug from plasma; tvVSyn the clearance of drug from synovial fluid; tvKap the rate of absorption of isoflupredone from the joint into the plasma in the absence of LPS; tvCLCSyn the clearance of drug from synovial fluid; dKapdLPS1 the effect of LPS on Kap; stdev0 the estimated residual standard deviation for plasma data; stdev1 the corresponding value for the synovial fluid data; HLplasma, the elimination half-life of drug from plasma; KapHL the half-life of absorption of the drug into plasma from synovial fluid in the absence of LPS; Syn_HL the elimination half-life of drug from synovial fluid; Kap_LPS the rate the rate of absorption of isoflupredone from the joint into the plasma during LPS; Kap_LPS_HL the half-life of absorption of the drug into plasma from synovial fluid during LPS administration